lobbying_activities: 3376573

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3376573	2657714b-e755-4b21-83a4-42004ad28cbe	Q2	VENABLE LLP	39941	AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS	2025	second_quarter	HCR	Increasing access to mental health and substance use treatment, including Methadone; Mental health & substance use disorder workforce; H.R. 3655, STAR Plus Scholarship Act; H.R. 1708/S. 1087, Rebuild America's Health Care Schools Act; Protect Medicaid from cuts; Federal funding for mental health and substance use programs, research and training; Medicare telehealth flexibilities; H.R. 2482, Reauthorization of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act; H.R. 2509/S. 931, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act; H.R. 2586, Reentry Act; H.R. 1510, Due Process Continuity of Care Act; Transparency and streamline utilization management protocols including prior authorization and step therapy (H.R. 8702/S. 4532); Preventing and reducing suicide (H.R. 3505, S. 1062, H.R. 1987, S. 926)	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2025-07-03T17:05:28-04:00